GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinitech Laboratory Ltd (BOM:544220) » Definitions » 3-Year EBITDA Growth Rate

Clinitech Laboratory (BOM:544220) 3-Year EBITDA Growth Rate : 5.50% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Clinitech Laboratory 3-Year EBITDA Growth Rate?

Clinitech Laboratory's EBITDA per Share for the six months ended in Sep. 2024 was ₹2.67.

During the past 12 months, Clinitech Laboratory's average EBITDA Per Share Growth Rate was 350.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of Clinitech Laboratory was 5.50% per year. The lowest was 5.50% per year. And the median was 5.50% per year.


Competitive Comparison of Clinitech Laboratory's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Clinitech Laboratory's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinitech Laboratory's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinitech Laboratory's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Clinitech Laboratory's 3-Year EBITDA Growth Rate falls into.



Clinitech Laboratory 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Clinitech Laboratory  (BOM:544220) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Clinitech Laboratory 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Clinitech Laboratory's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinitech Laboratory Business Description

Traded in Other Exchanges
N/A
Address
AL-1/545 and 546, Sector 16, Opposite Radhikabai Meghe Vidyalaya, Airoli, Navi Mumbai, MH, IND, 400708
Clinitech Laboratory Ltd is e a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane and Navi Mumbai. It conduct more than 150 tests such as Biochemistry tests, Immunology tests, Hematology tests, Molecular Biology tests, Serology tests, Microbiology tests, etc.

Clinitech Laboratory Headlines

No Headlines